AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness
NCT07205575
Acute Febrile Illness, Bacterial Infections
Jinan, Shandong, China
View Trial DetailsNCT Number: NCT02763462
This study is an observational cohort study of hospitalized patients with fever. This study will collect demographic data, history of illness, signs and symptoms, results of laboratory tests, clinical course, treatment and outcome. This study conducted at eight INA-RESPOND hospitals. Potential study patients will be any patients (both children and adults).
Looking for future studies?
Notify Me1 year and older
All sexes
Observational
University of Udayana/Sanglah Hospital, Denpasar, Bali, Indonesia
This study is an observational cohort to identify the etiologies of acute febrile illness (less than or equal to 2 weeks), which are thought to be endemic or novel in a certain area. Therefore, there are no hypotheses that require sample size calculation to be tested. It is expected that this study will enroll a minimum of 200 patients per site: approximately 100 adults and 100 pediatric cases. The final sample size is therefore estimated to be 1600.
Primary Objective:
To identify the etiology of acute febrile illness cases and evaluate clinical manifestations and outcomes.
Secondary Objectives:
This study will be conducted at all the INA-RESPOND hospitals (8 hospitals):
The study will enroll eligible fever patients for a period of up to 1 year. Follow-up may be up until one year after last subject is enrolled. Stored samples will be investigated during the study and/or after study completion.
After enrollment, patients will be seen at 14-28 days and at 3 months post enrollment. Patients will be seen every 3 months (6, 9, and 12 months within a window period of +/- 14 days) until cured and no related symptoms persists or the one year time point is reached. The samples will be collected for storage at enrollment, the 14-28 day visit, at 3 months and every 3 months thereafter if not cured.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Examples include, but not limited to: mental illness which could affect compliance with protocol, an anemic patient preventing blood draw.
Time frame: Total length of time the subject will be in the study is 3 months after enrollment or until cured or maximum 1 year.
Any pathogens identified as a caused of febrile illness based on laboratory tests such as blood culture, other culture (sputum/ pus/ urine/ feces), serology, and molecular.
Time frame: 3 years
The organ system affected induced clinical symptoms that provide essential information for improving clinical management in differentiating between each identified pathogen.
Time frame: 3 years
Eight clinical research sites in 7 cities in Indonesia have been established to conduct clinical research that improved research capacity and networking for Infectious diseases in Indonesia.
Time frame: 3 years
Each clinical research site and reference laboratory have been established to have capability to store repository specimen for future study.
Ina-Respond
Other
The Etiology of Acute Febrile Illness Requiring Hospitalization (AFIRE). A Multicenter Study of the Indonesia Research Partnership on Infectious Disease (INA-RESPOND)
Acronym: AFIRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07205575
Acute Febrile Illness, Bacterial Infections
Jinan, Shandong, China
View Trial DetailsNCT04081051
Acute Febrile Illness
Nanoro, Burkina Faso
View Trial DetailsNCT04299412
Acute Febrile Illness, Bacterial Infections
Darwin, Australia
View Trial DetailsNCT03943654
Acute Diarrhea, Acute Febrile Illness
Gressier, Ouest, Haiti
View Trial Details